Related Experiment Video
Updated: May 29, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
[Drug-drug interactions with HIV treatments]
E Mossdorf1, C Marzolini, D Fasel
1Klinik für Infektiologie und Spitalhygiene, Universitätsspital Basel. mossdorfe@gmx.ch
Praxis
|September 23, 2011
Summary
Diagnosing drug-drug interactions with boosted atazanavir requires a comprehensive medication review, including over-the-counter drugs. Pharmacologist consultation and therapeutic drug monitoring aid in managing complex interactions for effective combination antiretroviral therapy (cART).
Area of Science:
- Pharmacology
- Clinical Pharmacy
- Infectious Diseases
Background:
- Combination antiretroviral therapy (cART) is crucial for managing HIV.
- Boosted atazanavir is a common component of cART regimens.
- Drug-drug interactions (DDIs) pose a significant challenge in cART management.
Observation:
- New medications can interact with boosted atazanavir, altering its efficacy or toxicity.
- Patient history must include all prescribed and over-the-counter (OTC) medications.
- Physician communication regarding medication changes, side effects, and adherence is vital.
Findings:
- A systematic diagnostic approach is necessary to identify potential DDIs.
- Therapeutic drug monitoring (TDM) of cART is a key diagnostic tool.
- In complex cases, evaluation by a pharmacologist is recommended.
Implications:
- This approach enhances the safe and effective use of boosted atazanavir-based cART.
- Proactive DDI management improves patient outcomes and adherence.
- Interdisciplinary collaboration is essential for optimizing cART regimens.
More Related Videos
Related Concept Videos
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:23Factors Affecting Protein-Drug Binding: Drug Interactions
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
01:29Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.